Omeros (OMER) Revenue Growth (3y) (2013 - 2021)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 122.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.94% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.47% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 54.05% |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 86.73% |
| Jun 30, 2021 | 159.21% |
| Mar 31, 2021 | 136.71% |
| Dec 31, 2020 | -8.24% |
| Sep 30, 2020 | 6.44% |
| Jun 30, 2020 | -7.60% |
| Mar 31, 2020 | 24.30% |
| Dec 31, 2019 | 37.32% |
| Sep 30, 2019 | 38.29% |
| Jun 30, 2019 | 38.80% |
| Mar 31, 2019 | 43.18% |
| Dec 31, 2018 | 48.86% |
| Sep 30, 2018 | 12.24% |
| Jun 30, 2018 | -19.62% |
| Mar 31, 2018 | 59.96% |
| Dec 31, 2017 | 324.41% |
| Sep 30, 2017 | 366.02% |
| Jun 30, 2017 | 625.04% |
| Mar 31, 2017 | 396.74% |
| Dec 31, 2016 | 324.25% |
| Sep 30, 2016 | 286.19% |
| Jun 30, 2016 | 314.97% |
| Mar 31, 2016 | 89.22% |
| Dec 31, 2015 | 61.56% |
| Sep 30, 2015 | 32.00% |
| Jun 30, 2015 | 27.82% |
| Mar 31, 2015 | -36.23% |
| Dec 31, 2014 | -46.00% |
| Sep 30, 2014 | -39.92% |
| Jun 30, 2014 | -66.10% |
| Mar 31, 2014 | -56.78% |
| Dec 31, 2013 | -44.26% |
| Sep 30, 2013 | -8.28% |
| Jun 30, 2013 | -34.45% |